Funder: ALS Association
Due Dates: August 12, 2025 (Opens) | September 23, 2025 (LOI) | January 13, 2026 (Full Application)
Funding Amounts: Up to $12 million direct costs per project (up to 5 years); total funds available: up to $60 million.
Summary: Supports high-quality, patient-centered comparative effectiveness research on rare diseases, emphasizing symptom management, diagnosis, and care delivery.
Key Information: Projects must address PCORI’s Foundational Expectations for Partnerships in Research.